image
Healthcare - Biotechnology - NASDAQ - US
$ 0.773
-3.71 %
$ 69.3 M
Market Cap
-1.76
P/E
BALANCE SHEET
98.1 M ASSETS
510.90%
2.86 M LIABILITIES
-31.76%
95.3 M EQUITY
702.51%
BALANCE SHEET DECOMPOSITION
Balance Sheet Context Therapeutics Inc.
image
Current Assets 97.9 M
Cash & Short-Term Investments 94.4 M
Receivables 0
Other Current Assets 3.47 M
Non-Current Assets 231 K
Long-Term Investments 0
PP&E 231 K
Other Non-Current Assets 0
96.23 %3.53 %Total Assets$98.1m
Current Liabilities 2.75 M
Accounts Payable 1.45 M
Short-Term Debt 107 K
Other Current Liabilities 1.19 M
Non-Current Liabilities 112 K
Long-Term Debt 0
Other Non-Current Liabilities 112 K
50.77 %3.75 %41.56 %3.92 %Total Liabilities$2.9m

Balance Sheet

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019
ASSETS
Cash & Cash Equivalents 94.4 14.4 35.5 49.6 0.3 0.2
Short Term Investments 0 0 0 0 0 0
Receivables 0 0 0 0 0 0
Inventory 0 0 0 0 0 0
Other Current Assets 3.5 1.6 2.4 3.2 8.67 K 13 K
Total Current Assets 97.9 16.0 37.9 51.3 0.3 0.2
PP&E 0.2 15.5 K 79.5 K 0 0 0
Intangible Assets 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0
Long Term Investments 0 0 0 50.4 K 0 0
Other Long Term Assets 0 0 32.8 K 0 0.1 33.9 K
Other Assets 0 0 0 0 0 0
Total Assets 98.1 16.1 38.0 51.3 0.5 0.3
LIABILITIES
Accounts Payable 1.5 2.4 0.9 1.8 2.7 2.1
Short Term Debt 0.1 0 0.1 0 5.9 21.8
Other Current Liabilities 1.2 1.8 2.2 1.2 1.0 0.2
Total Current Liabilities 2.7 4.2 3.2 3.0 9.5 24.1
Long Term Debt 0 0 0 0 69 K 0
Deferred Tax Income 0 0 0 0 0 0
Other Liabilities 0 0 0 0 7.8 0.1
Total Liabilities 2.9 4.2 3.2 3.0 17.4 24.2
EQUITY
Common Stock 89.7 K 16 K 16 K 16 K 332 324
Retained Earnings (94.8) (68.1) (44.1) (29.3) (18.8) (25.4)
Other Accumulative Comprehensive Income/Loss 0 0 0 (51.3) (7.8) (0.1)
Total Equity 95.3 11.9 34.8 48.3 (16.9) (24.0)
Total Liabilities and Equity 98.1 16.1 38.0 51.3 0.5 0.3
SHARES OUTSTANDING
Common Shares Outstanding 58.4 16.0 16.0 16.0 11.0 11.0